Case Reports in Hematology / 2013 / Article / Fig 1

Case Report

Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma

Figure 1

Images showing Hodgkin lymphoma refractory to induction chemotherapy. (a) Chest computerized tomography (CT) demonstrates the superior mediastinal tumor at diagnosis. (b) Positron emission tomography/computerized tomography (PET/CT) reveals involvement of right supraclavicular, left lower neck, mediastinal, epicardial, and retroperitoneal lymph nodes at initial diagnosis. (c) PET/CT after 4 cycles of induction chemotherapy shows partial remission with a residual uptake at right anterior mediastinum. (d) PET/CT after completion of 6 cycles of chemotherapy reveals relapse of the mediastinal tumor.
351292.fig.001a
(a)
351292.fig.001b
(b)
351292.fig.001c
(c)
351292.fig.001d
(d)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.